Cidara Therapeutics (CDTX) Prices 2.48M Common Stock Offering at $10.10/Share

October 7, 2016 9:04 AM EDT
Get Alerts CDTX Hot Sheet
Trade CDTX Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Cidara Therapeutics, Inc. (Nasdaq: CDTX) announced the pricing of an underwritten public offering of 2,475,248 shares of its common stock at a price to the public of $10.10 per share. The gross proceeds to Cidara from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $25.0 million. The offering is expected to close on or about October 12, 2016, subject to customary closing conditions. In addition, the underwriter has been granted a 30-day option to purchase up to an additional 371,287 shares of its common stock at the public offering price.

Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering.

The securities described above are being offered by Cidara pursuant to a shelf registration statement, which has been declared effective by the Securities and Exchange Commission. A preliminary prospectus supplement and accompanying prospectus relating to the offering have been filed with the SEC and are available for free on the SEC's website at Copies of the final prospectus supplement and accompanying prospectus relating to the offering, when available, may be obtained from: Cantor Fitzgerald & Co., Attn: Capital Markets, 499 Park Ave., 6th Floor, New York, New York 10022, or by telephone at 212-829-7122, or by e-mail at

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Equity Offerings

Related Entities

Cantor Fitzgerald

Add Your Comment